Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China

BACKGROUND: In China, gastric cancer (GC) ranks second in incidence and mortality. Over 80% of patients with GC were diagnosed at an advanced stage with poor clinical outcome. Chemotherapy was the mainstream treatment with limited benefit. Apatinib, an inhibitor of targeting vascular endothelial gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wanren, Zhang, Fenglin, Wang, Zishu, Li, Dongliang, He, Yifu, Ning, Zhongliang, Sheng, Lili, Wang, Jidong, Xia, Xiaoyang, Yu, Changjun, Wang, Zian, Zhao, Yong, Liang, Hui, Hu, Bing, Sun, Cuiling, Wang, Daoqin, Cheng, Yunsheng, Pan, Ming, Xia, Liming, Guo, Xinglai, Zhang, Yanshun, Hu, Zhiqiang, Li, Xinzhong, Lu, Lin, Zhang, Jun, Qian, Hong, Xie, Hua, Sun, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418160/
https://www.ncbi.nlm.nih.gov/pubmed/32821164
http://dx.doi.org/10.2147/CMAR.S249153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418160/
https://www.ncbi.nlm.nih.gov/pubmed/32821164
http://dx.doi.org/10.2147/CMAR.S249153

Ejemplares similares